"Immunologic Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.
| Descriptor ID |
D007155
|
| MeSH Number(s) |
D27.505.696.477
|
| Concept/Terms |
Immunologic Factors- Immunologic Factors
- Immune Factors
- Factors, Immune
- Immunological Factors
- Factors, Immunological
- Factors, Immunologic
|
Below are MeSH descriptors whose meaning is more general than "Immunologic Factors".
Below are MeSH descriptors whose meaning is more specific than "Immunologic Factors".
This graph shows the total number of publications written about "Immunologic Factors" by people in this website by year, and whether "Immunologic Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 2 | 0 | 2 |
| 2008 | 0 | 4 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 3 | 7 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 2 | 4 |
| 2015 | 4 | 2 | 6 |
| 2016 | 7 | 2 | 9 |
| 2017 | 66 | 51 | 117 |
| 2018 | 90 | 37 | 127 |
| 2019 | 37 | 24 | 61 |
| 2020 | 65 | 57 | 122 |
| 2021 | 21 | 42 | 63 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunologic Factors" by people in Profiles.
-
Immune dysregulation and system pathology in COVID-19. Virulence. 2021 12; 12(1):918-936.
-
History repeats itself: horse originated hyperimmune sera production against SARS CoV-2 Turk J Med Sci. 2021 10 21; 51(5):2263-2273.
-
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8. Pharmacol Res Perspect. 2021 10; 9(5):e00842.
-
Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis. Crit Care Med. 2021 10 01; 49(10):1717-1725.
-
The role of type I interferon in the treatment of COVID-19. J Med Virol. 2022 01; 94(1):63-81.
-
Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019. J Infect Dis. 2021 09 17; 224(6):934-937.
-
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19. J Gerontol A Biol Sci Med Sci. 2021 09 13; 76(10):1775-1783.
-
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis. Rev Med Virol. 2021 11; 31(6):e2288.
-
Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop. J Neuroimmune Pharmacol. 2021 09; 16(3):519-530.